INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $264,659 | -36.2% | 8,370 | -17.7% | 0.56% | -13.6% |
Q2 2023 | $414,896 | +2.3% | 10,174 | -6.5% | 0.64% | +8.4% |
Q1 2023 | $405,758 | -5.7% | 10,887 | -11.7% | 0.59% | +8.0% |
Q4 2022 | $430,263 | -54.5% | 12,332 | -27.0% | 0.55% | -41.0% |
Q3 2022 | $945,000 | +8.9% | 16,884 | +0.7% | 0.93% | +16.4% |
Q2 2022 | $868,000 | -40.2% | 16,770 | -16.1% | 0.80% | +1.1% |
Q1 2022 | $1,452,000 | -58.5% | 19,980 | -32.5% | 0.79% | -35.1% |
Q4 2021 | $3,498,000 | -0.3% | 29,586 | +13.1% | 1.22% | +3.6% |
Q3 2021 | $3,508,000 | +10.1% | 26,153 | +32.9% | 1.17% | +0.4% |
Q2 2021 | $3,186,000 | +256.8% | 19,676 | +76.8% | 1.17% | +193.5% |
Q1 2021 | $893,000 | – | 11,130 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |